88 results
8-K
EX-10.1
BLPH
Bellerophon Therapeutics, Inc.
30 Jan 24
Entry into a Material Definitive Agreement
9:29am
8-K
EX-10.1
BLPH
Bellerophon Therapeutics, Inc.
9 Jun 23
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
izij cz21l
5 May 23
Departure of Directors or Certain Officers
4:59pm
8-K
EX-10.1
925rllh1u 5h
6 Mar 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.1
f9bs3tbudkvprlkte0yn
28 Jan 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
m6k2xe7gv pyg1l9
17 Jul 20
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-10.1
cub3ohm2qnv 4py
20 May 20
Bellerophon Therapeutics Announces Proposed Public Offering of Common Stock
4:04pm
8-K
EX-10.1
g400bqvx8peggho7gpnl
30 Mar 20
Bellerophon Announces $15.3 Million Registered Direct Offering Priced At-the-Market
4:09pm
8-K
EX-10.1
kanto1 d9xf
17 Dec 19
Statistically Significant Improvement Demonstrated in Moderate to Vigorous Physical Activity
8:24am
8-K
EX-10.2
85nmq6lo4yphaenukt
26 Apr 18
Entry into a Material Definitive Agreement
9:51am
8-K
EX-10.1
se265j yw6
26 Apr 18
Entry into a Material Definitive Agreement
9:51am
8-K
EX-10.3
2rmos11grpp8ewqwz1
27 Sep 17
Bellerophon Announces $23 Million Private Placement
12:00am
8-K
EX-10.1
8gc40g5qxwt2 xqtb2
27 Sep 17
Bellerophon Announces $23 Million Private Placement
12:00am
8-K
EX-10.2
yzpgm7u45 cynij2lkpl
27 Sep 17
Bellerophon Announces $23 Million Private Placement
12:00am
8-K
EX-10.2
30ikg50s6piwd71
12 May 17
Bellerophon Announces $3.0 Million Registered Direct Offering
12:00am
8-K
EX-10.1
49s mqzne
12 May 17
Bellerophon Announces $3.0 Million Registered Direct Offering
12:00am